{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-331207","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2026-08-04T01:54:29+00:00","discovered_at":"2026-08-04T10:05:00.617130+00:00","generated_at":"2026-08-04T10:05:33.931432+00:00","sec_items":["1.01","2.01","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Galera Therapeutics completes merger with Obsidian; becomes subsidiary of Obsidian Therapeutics","bullets":["Galera shareholders receive 0.7019 shares of Parent common stock per share; Legacy Obsidian shareholders receive 0.1383 shares per share.","Post-merger ownership: Legacy Obsidian ~51.6%, PIPE investors ~47.2%, Galera ~1.2% on fully diluted basis.","Galera shareholders receive CVRs: 80% of net proceeds from Legacy Product (tilarganine) over 5 years, 95% from Supportive-Care divestiture over 10 years.","Galera common stock to be delisted from OTCQB; company to file Form 15 to terminate SEC registration.","All prior directors resigned; new officers appointed (Madan Jagasia, Julie Feder, Parameswaran Hari, Dana Alexander)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-331207","json":"https://secwatch.observer/filing/0001193125-26-331207.json","markdown":"https://secwatch.observer/filing/0001193125-26-331207.md","text":"https://secwatch.observer/filing/0001193125-26-331207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526331207/0001193125-26-331207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526331207/d170816d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T10:05:33.931432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}